Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 240

1.

Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.

Endo K, Koga M, Sakai N, Yamagami H, Furui E, Matsumoto Y, Shiokawa Y, Yoshimura S, Okada Y, Nakagawara J, Hyogo T, Hasegawa Y, Nagashima H, Fujinaka T, Hyodo A, Terada T, Toyoda K; Joint Research Group from JR-NET2 and SAMURAI Study Investigators.

J Stroke Cerebrovasc Dis. 2013 Aug;22(6):805-10. doi: 10.1016/j.jstrokecerebrovasdis.2012.05.009. Epub 2012 Jun 19.

PMID:
22721823
[PubMed - indexed for MEDLINE]
2.

Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.

Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K.

Cerebrovasc Dis. 2012;34(2):140-6. doi: 10.1159/000339759. Epub 2012 Aug 1.

PMID:
22854333
[PubMed - indexed for MEDLINE]
3.

Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.

Roveri L, La Gioia S, Ghidinelli C, Anzalone N, De Filippis C, Comi G.

J Stroke Cerebrovasc Dis. 2013 Aug;22(6):703-8. doi: 10.1016/j.jstrokecerebrovasdis.2011.10.003. Epub 2011 Nov 30.

PMID:
22133742
[PubMed - indexed for MEDLINE]
4.

Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.

Koga M, Arihiro S, Miyashita F, Yamamoto H, Yamada N, Nagatsuka K, Minematsu K, Toyoda K.

Cerebrovasc Dis. 2013;36(4):299-305. doi: 10.1159/000355054. Epub 2013 Oct 16.

PMID:
24135558
[PubMed - indexed for MEDLINE]
5.

Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.

Zaidat OO, Suarez JI, Santillan C, Sunshine JL, Tarr RW, Paras VH, Selman WR, Landis DM.

Stroke. 2002 Jul;33(7):1821-6.

PMID:
12105360
[PubMed - indexed for MEDLINE]
Free Article
6.

Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.

Miyagi T, Koga M, Shiokawa Y, Nakagawara J, Hasegawa Y, Furui E, Kimura K, Kario K, Okuda S, Yamagami H, Okada Y, Nezu T, Maeda K, Endo K, Minematsu K, Toyoda K.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1098-106. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.013. Epub 2012 Oct 10.

PMID:
23063059
[PubMed - indexed for MEDLINE]
7.

Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.

Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.

J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.

PMID:
21968092
[PubMed - indexed for MEDLINE]
8.

Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?

Hassan AE, Chaudhry SA, Jani V, Grigoryan M, Khan AA, Adil MM, Qureshi AI.

J Stroke Cerebrovasc Dis. 2013 May;22(4):545-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.022. Epub 2013 Feb 28.

PMID:
23453555
[PubMed - indexed for MEDLINE]
9.

Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.

Deguchi I, Takeda H, Furuya D, Dembo T, Nagoya H, Kato Y, Ito Y, Fukuoka T, Maruyama H, Tanahashi N.

J Stroke Cerebrovasc Dis. 2012 Feb;21(2):108-13. doi: 10.1016/j.jstrokecerebrovasdis.2010.03.019. Epub 2010 Sep 19. Erratum in: J Stroke Cerebrovasc Dis. 2012 May;21(4):342.

PMID:
20851627
[PubMed - indexed for MEDLINE]
10.

Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit.

Yoneda Y, Yamamoto S, Hara Y, Ohta K, Matsushita M, Yamamoto D, Yamashita H, Hosoda K.

Clin Neurol Neurosurg. 2007 Sep;109(7):567-70. Epub 2007 Jun 15.

PMID:
17573188
[PubMed - indexed for MEDLINE]
11.

Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register.

Toyoda K, Koga M, Naganuma M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement Study Investigators.

Stroke. 2009 Nov;40(11):3591-5. doi: 10.1161/STROKEAHA.109.562991. Epub 2009 Sep 17.

PMID:
19762694
[PubMed - indexed for MEDLINE]
Free Article
12.

Intravenous thrombolysis for acute cerebral ischaemia: comparison of outcomes between patients treated at working versus nonworking hours.

Bodenant M, Leys D, Debette S, Cordonnier C, Dumont F, Hénon H, Girot M, Lucas C, Devos D, Defebvre L, Deplanque D, Leclerc X, Bordet R.

Cerebrovasc Dis. 2010;30(2):148-56. doi: 10.1159/000316058. Epub 2010 Jun 10.

PMID:
20551630
[PubMed - indexed for MEDLINE]
13.

Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).

Mori E, Minematsu K, Nakagawara J, Yamaguchi T; Japan Alteplase Clinical Trial (J-ACT) Group.

J Stroke Cerebrovasc Dis. 2011 Nov;20(6):517-22. doi: 10.1016/j.jstrokecerebrovasdis.2010.04.001. Epub 2010 Aug 17.

PMID:
20719535
[PubMed - indexed for MEDLINE]
14.

Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.

Hirano T, Sasaki M, Tomura N, Ito Y, Kobayashi S; Japan Alteplase Clinical Trial Group.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):898-902. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.018. Epub 2011 Jul 7.

PMID:
21737309
[PubMed - indexed for MEDLINE]
15.

Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.

Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO.

J Stroke Cerebrovasc Dis. 2008 May-Jun;17(3):121-8. doi: 10.1016/j.jstrokecerebrovasdis.2007.12.004.

PMID:
18436152
[PubMed - indexed for MEDLINE]
16.

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

Huisa BN, Raman R, Neil W, Ernstrom K, Hemmen TM.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):732-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.03.009. Epub 2011 Apr 30.

PMID:
21531576
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[Prospects of thrombolytic therapy for acute ischemic stroke].

Nakashima T, Minematsu K.

Brain Nerve. 2009 Sep;61(9):1003-12. Review. Japanese.

PMID:
19803399
[PubMed - indexed for MEDLINE]
18.

Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).

Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Dávalos A, Erilä T, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Köhrmann M, Larrue V, Lees KR, Machnig T, Roine RO, Toni D, Vanhooren G; Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy Investigators.

Stroke. 2008 Dec;39(12):3316-22. doi: 10.1161/STROKEAHA.107.510768. Epub 2008 Oct 16.

PMID:
18927461
[PubMed - indexed for MEDLINE]
Free Article
19.

Efficacy and safety of a modified intravenous recombinant tissue plasminogen activator regimen in Chinese patients with acute ischemic stroke.

Pan SM, Liu JF, Liu M, Shen S, Li HJ, Dai LH, Chen XJ.

J Stroke Cerebrovasc Dis. 2013 Jul;22(5):690-3. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.018. Epub 2012 Oct 27.

PMID:
23111010
[PubMed - indexed for MEDLINE]
20.

Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA.

JAMA. 2000 Mar 1;283(9):1145-50.

PMID:
10703776
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk